You just read:

Late-Breaking Results from XARELTO® PIONEER AF-PCI Study Among 18 New Studies Accepted for Presentation at the American Heart Association Scientific Sessions 2016

News provided by

Janssen Pharmaceuticals, Inc.

07 Nov, 2016, 08:00 ET